BEAM Research and Charts

BEAM - Beam Therapeutics Inc (Healthcare: Biotechnology)

Projected Earnings Date: 2025-08-05 (Delayed quote data 2025-07-11)

Last 21.16	Change ⇓ -0.87 (-3.95%)	Volume 2,296,116
	Open 21.73	High 22.18	Low 20.95

8EMA (Daily) 19.97	40EMA (Daily) 18.34	50EMA (Daily) 18.49	STO (Daily) 87.985	MACD Hist (Daily) 1.135
8EMA (Weekly) 18.732	40EMA (Weekly) 21.81	50EMA (Weekly) 22.59	STO (Weekly) 49.905	MACD Hist (Weekly) 0.849


Company Profile
Beam Therapeutics Inc is a biotechnology company engaged in creating genetic medicines based on its base editing technology. This technology enables a new class of genetic medicines that targets a single base in the genome without making a double-stranded break in the DNA. The company's portfolio comprises Gene Correction, Gene Modification, Gene Activation, Gene Silencing, and Multiplex Editing.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.